Vivoryon Therapeutics Overview
- Founded
- 1997
- Status
- Public
- Employees
- 14
- Stock Symbol
- VVY
- Investments
- 1
- Share Price
- $16.99
- (As of Monday Closing)
Vivoryon Therapeutics General Information
Description
Vivoryon Therapeutics NV is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Contact Information
Website
Formerly Known As
ProBioTec, Probiodrug
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
AMS
Primary Office
- Weinbergweg 22
- 06120 Halle
- Germany
+49 0345 0000000
Vivoryon Therapeutics Timeline
Vivoryon Therapeutics Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.99 | $18.32 | $3.51 - $25.33 | $339M | 20M | 212K | -$0.76 |
Vivoryon Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 42,456 | 112,748 | 16,423 | 87,327 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (13,262) | (8,538) | (9,057) | (11,114) |
| Net Income | (13,607) | (8,757) | (9,130) | (9,032) |
| Total Assets | 42,625 | 51,372 | 4,631 | 12,911 |
| Total Debt | 405 | 455 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Vivoryon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Vivoryon Therapeutics‘s full profile, request access.
Request a free trialVivoryon Therapeutics Executive Team (12)
Vivoryon Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialVivoryon Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Vivoryon Therapeutics‘s full profile, request access.
Request a free trialVivoryon Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 25-Jun-2007 | 000000000000000000 | Pharmaceuticals |